RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1
Loss of function of tuberous sclerosis complex 1 or 2 (TSC1 or TSC2) leads to the activation of mammalian target of rapamycin complex 1 (mTORC1). Hyperactivated mTORC1 plays a critical role in tumor growth, but the underlying mechanism is still not completely elucidated. Here, by analyzing Tsc1- or...
Guardado en:
Autores principales: | Wei Lin, Xiaofeng Wan, Anjiang Sun, Meng Zhou, Xu Chen, Yanling Li, Zixi Wang, Hailiang Huang, Hongwu Li, Xianguo Chen, Juan Hua, Xiaojun Zha |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67595c2674834a9192202460a32169d2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Multiple Interactions of RUNX with the Hippo–YAP Pathway
por: Linda Shyue Huey Chuang, et al.
Publicado: (2021) -
The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses
por: Danrui Cui, et al.
Publicado: (2021) -
Control of protein synthesis and memory by GluN3A-NMDA receptors through inhibition of GIT1/mTORC1 assembly
por: María J Conde-Dusman, et al.
Publicado: (2021) -
Polymorphisms in DSSP (rs36094464) and RUNX2 (rs566712) Genes Contribute to the Susceptibility of Dental Caries in Childhood
por: Sanhueza,Jorge, et al.
Publicado: (2021) -
Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway
por: Li,Ling, et al.
Publicado: (2019)